US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 2.3150
  • -0.1150-4.73%
Close Nov 6 16:00 ET
28.11MMarket Cap-786P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
20.37%5.56M
30.37%5.99M
-27.21%16.81M
-20.65%4.62M
-12.39%4.59M
34.12%23.09M
34.32%5.82M
-5.49%5.24M
-4.26%17.21M
-14.84%5.87M
Selling and administrative expenses
-27.50%2.24M
29.58%3.71M
-16.05%11.36M
4.25%3.09M
-7.78%2.86M
67.40%13.53M
38.12%2.97M
53.74%3.1M
-11.79%8.08M
-9.58%2.02M
-General and administrative expense
-27.50%2.24M
29.58%3.71M
-16.05%11.36M
4.25%3.09M
-7.78%2.86M
67.40%13.53M
38.12%2.97M
53.74%3.1M
-11.79%8.08M
-9.58%2.02M
Research and development costs
117.45%3.31M
31.66%2.28M
-43.00%5.45M
-46.55%1.52M
-19.10%1.73M
4.68%9.56M
30.58%2.85M
-39.38%2.14M
3.55%9.13M
-17.37%3.85M
Operating profit
-20.37%-5.56M
-30.37%-5.99M
27.21%-16.81M
20.65%-4.62M
12.39%-4.59M
-34.12%-23.09M
-34.32%-5.82M
5.49%-5.24M
4.26%-17.21M
14.84%-5.87M
Net non-operating interest income expense
-268.97%-49K
-93.33%2K
78.26%82K
633.25%29K
587.76%30K
333.96%46K
161.06%3.96K
16.79%4.36K
-22.14%10.6K
-25.22%3.98K
Non-operating interest income
-93.10%2K
-93.33%2K
78.26%82K
633.25%29K
587.76%30K
333.96%46K
161.06%3.96K
16.79%4.36K
-22.14%10.6K
-25.22%3.98K
Non-operating interest expense
--51K
----
----
--0
----
----
----
----
----
----
Other net income (expense)
-433.45%-1.95M
-92.43%421K
26.86%6.72M
343.20%586K
8,701.48%5.57M
2,498.72%5.29M
840.76%132.22K
121.54%63.23K
-124.92%-220.7K
-0.37%80.04K
Gain on sale of security
-110.02%-60K
-92.41%423K
23.90%6.74M
323.55%599K
7,827.55%5.58M
2,913.39%5.44M
1,208.86%141.42K
124.61%70.34K
-121.29%-193.22K
-1.58%91.17K
Special income (charges)
---1.89M
----
----
--0
----
----
----
----
----
----
-Less：Restructuring and merger&acquisition
--1.89M
----
----
--0
----
----
----
----
----
----
Other non- operating income (expenses)
----
81.82%-2K
86.62%-19K
-41.23%-13K
-54.73%-11K
-416.70%-142K
-80.67%-9.21K
7.82%-7.11K
-24.88%-27.48K
9.49%-11.12K
Income before tax
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
15.00%-5.79M
Income tax
Net income
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
15.00%-5.79M
Net income continuous Operations
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
15.00%-5.79M
Minority interest income
Net income attributable to the parent company
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
15.00%-5.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
11.34%-5.18M
-2.01%-17.42M
15.00%-5.79M
Basic earnings per share
-1.46%-0.8025
-408.94%-0.8275
64.03%-2.0447
58.68%-0.7909
113.86%0.2678
29.98%-5.6853
15.28%-1.9141
36.34%-1.9321
59.40%-8.1192
82.01%-2.4904
Diluted earnings per share
-1.46%-0.8025
-413.03%-0.8275
64.03%-2.0447
58.68%-0.7909
113.68%0.2643
29.98%-5.6853
15.28%-1.9141
36.34%-1.9321
59.40%-8.1192
82.01%-2.4904
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q2)Jun 30, 2022 (Q1)Mar 31, 2022 (FY)Dec 31, 2021 (Q4)Dec 31, 2021
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 20.37%5.56M 30.37%5.99M -27.21%16.81M -20.65%4.62M -12.39%4.59M 34.12%23.09M 34.32%5.82M -5.49%5.24M -4.26%17.21M -14.84%5.87M
Selling and administrative expenses -27.50%2.24M 29.58%3.71M -16.05%11.36M 4.25%3.09M -7.78%2.86M 67.40%13.53M 38.12%2.97M 53.74%3.1M -11.79%8.08M -9.58%2.02M
-General and administrative expense -27.50%2.24M 29.58%3.71M -16.05%11.36M 4.25%3.09M -7.78%2.86M 67.40%13.53M 38.12%2.97M 53.74%3.1M -11.79%8.08M -9.58%2.02M
Research and development costs 117.45%3.31M 31.66%2.28M -43.00%5.45M -46.55%1.52M -19.10%1.73M 4.68%9.56M 30.58%2.85M -39.38%2.14M 3.55%9.13M -17.37%3.85M
Operating profit -20.37%-5.56M -30.37%-5.99M 27.21%-16.81M 20.65%-4.62M 12.39%-4.59M -34.12%-23.09M -34.32%-5.82M 5.49%-5.24M 4.26%-17.21M 14.84%-5.87M
Net non-operating interest income expense -268.97%-49K -93.33%2K 78.26%82K 633.25%29K 587.76%30K 333.96%46K 161.06%3.96K 16.79%4.36K -22.14%10.6K -25.22%3.98K
Non-operating interest income -93.10%2K -93.33%2K 78.26%82K 633.25%29K 587.76%30K 333.96%46K 161.06%3.96K 16.79%4.36K -22.14%10.6K -25.22%3.98K
Non-operating interest expense --51K ---- ---- --0 ---- ---- ---- ---- ---- ----
Other net income (expense) -433.45%-1.95M -92.43%421K 26.86%6.72M 343.20%586K 8,701.48%5.57M 2,498.72%5.29M 840.76%132.22K 121.54%63.23K -124.92%-220.7K -0.37%80.04K
Gain on sale of security -110.02%-60K -92.41%423K 23.90%6.74M 323.55%599K 7,827.55%5.58M 2,913.39%5.44M 1,208.86%141.42K 124.61%70.34K -121.29%-193.22K -1.58%91.17K
Special income (charges) ---1.89M ---- ---- --0 ---- ---- ---- ---- ---- ----
-Less：Restructuring and merger&acquisition --1.89M ---- ---- --0 ---- ---- ---- ---- ---- ----
Other non- operating income (expenses) ---- 81.82%-2K 86.62%-19K -41.23%-13K -54.73%-11K -416.70%-142K -80.67%-9.21K 7.82%-7.11K -24.88%-27.48K 9.49%-11.12K
Income before tax -88.95%-7.56M -656.04%-5.57M 43.61%-10.01M 29.58%-4M 119.34%1M -1.86%-17.75M -30.68%-5.68M 11.34%-5.18M -2.01%-17.42M 15.00%-5.79M
Income tax
Net income -88.95%-7.56M -656.04%-5.57M 43.61%-10.01M 29.58%-4M 119.34%1M -1.86%-17.75M -30.68%-5.68M 11.34%-5.18M -2.01%-17.42M 15.00%-5.79M
Net income continuous Operations -88.95%-7.56M -656.04%-5.57M 43.61%-10.01M 29.58%-4M 119.34%1M -1.86%-17.75M -30.68%-5.68M 11.34%-5.18M -2.01%-17.42M 15.00%-5.79M
Minority interest income
Net income attributable to the parent company -88.95%-7.56M -656.04%-5.57M 43.61%-10.01M 29.58%-4M 119.34%1M -1.86%-17.75M -30.68%-5.68M 11.34%-5.18M -2.01%-17.42M 15.00%-5.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -88.95%-7.56M -656.04%-5.57M 43.61%-10.01M 29.58%-4M 119.34%1M -1.86%-17.75M -30.68%-5.68M 11.34%-5.18M -2.01%-17.42M 15.00%-5.79M
Basic earnings per share -1.46%-0.8025 -408.94%-0.8275 64.03%-2.0447 58.68%-0.7909 113.86%0.2678 29.98%-5.6853 15.28%-1.9141 36.34%-1.9321 59.40%-8.1192 82.01%-2.4904
Diluted earnings per share -1.46%-0.8025 -413.03%-0.8275 64.03%-2.0447 58.68%-0.7909 113.68%0.2643 29.98%-5.6853 15.28%-1.9141 36.34%-1.9321 59.40%-8.1192 82.01%-2.4904
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- Unqualified Opinion with Explanatory Notes -- -- Unqualified Opinion with Explanatory Notes -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data